Polycystic kidney disease (PKD) is caused by inherited gene mutations that trigger fluid-filled cysts to grow throughout the kidneys. There are two main forms, each caused by different genes and inherited in different ways, but both lead to progressive kidney enlargement as cysts multiply and expand over years or decades.
The Two Genetic Forms of PKD
The dominant form, called ADPKD, is one of the most common genetic diseases in humans. It requires only one copy of a faulty gene (inherited from one parent) to develop. Over 90 percent of diagnosed families carry a mutation in one of two genes: PKD1 or PKD2. Which gene is affected matters quite a bit. People with PKD1 mutations typically reach kidney failure around age 54, while those with PKD2 mutations follow a slower course, with kidney failure arriving around age 74 on average.
The recessive form, ARPKD, is far rarer, affecting roughly 1 in 20,000 children. It’s caused by mutations in a gene called PKHD1, and a child must inherit a defective copy from both parents to develop the disease. When two carrier parents have a child, there’s a 25 percent chance that child will be affected. ARPKD tends to be more severe and presents earlier in life, often detected before birth or in infancy.
You Don’t Always Need a Family History
Most people with ADPKD inherit the mutation from a parent who also has the disease. But 4 to 10 percent of cases arise from spontaneous, or “de novo,” mutations, meaning the genetic error appeared for the first time in that person. If you’ve been diagnosed and no one in your family has PKD, that doesn’t rule it out. It simply means the mutation started with you, and you can still pass it to your children with a 50 percent probability per pregnancy.
How a Gene Mutation Becomes a Cyst
The PKD1 and PKD2 genes produce proteins called polycystins, which sit on tiny hair-like sensors (called primary cilia) on the surface of kidney cells. These proteins help cells detect fluid flow and regulate their own growth. When the proteins are defective, calcium signaling inside the cell drops, which sets off a chain reaction. A signaling molecule called cyclic AMP (cAMP) rises to abnormal levels, and this drives two things simultaneously: the cells lining kidney tubules start multiplying when they shouldn’t, and they begin pumping chloride and water into enclosed spaces, inflating cysts like tiny balloons.
The process resembles tumor growth in some ways. Once a cyst gets started, additional genetic hits and environmental factors can favor its survival and expansion. Individual cysts eventually pinch off from the tubule they originated in, becoming self-contained sacs that keep growing independently. Over time, a kidney that normally weighs about 150 grams can swell to several kilograms.
What Drives Cysts to Keep Growing
A hormone called vasopressin, which your body produces to concentrate urine and conserve water, plays a surprisingly central role in cyst growth. Vasopressin binds to receptors on cyst-lining cells and ramps up cAMP production, which accelerates both cell proliferation and fluid secretion into cysts. This is why staying well-hydrated is often recommended for people with PKD: suppressing vasopressin release may slow the cycle. It’s also the principle behind one of the main medications now used to manage the disease, which blocks vasopressin’s receptor.
The fluid accumulation inside cysts depends on chloride channels on the cell surface. Vasopressin activates these channels, pulling chloride (and water following it) into the cyst cavity. Blocking these channels in lab experiments completely stops vasopressin-driven fluid secretion, confirming how tightly the hormone controls cyst inflation.
Why Some People Progress Faster
Not everyone with PKD loses kidney function at the same rate, even within the same family. Several factors influence how quickly cysts grow and kidneys decline.
- Gene type: PKD1 mutations cause larger kidneys and earlier kidney failure than PKD2 mutations, a difference of roughly 20 years on average.
- Blood pressure: High blood pressure correlates strongly with cyst burden. People who develop elevated blood pressure early, even while kidney function still looks normal on blood tests, tend to have larger kidneys. The relationship works both ways: bigger kidneys promote higher blood pressure, and higher blood pressure accelerates kidney damage.
- Kidney volume: Total kidney volume measured on imaging is one of the strongest predictors of future decline. Larger kidneys at baseline predict faster progression, which is why imaging is used to stratify risk.
- Blood flow: Reduced blood flow to the kidneys is an independent risk factor for progression, separate from blood pressure alone.
There’s also a hormonal feedback loop that worsens things. As cysts compress normal kidney tissue, the kidneys produce more renin, a hormone that raises blood pressure. But renin also acts as a direct growth signal for cyst-lining cells, potentially promoting further cyst expansion. About 40 percent of people with ADPKD who have prehypertension or hypertension show a “nondipping” pattern, meaning their blood pressure doesn’t drop normally during sleep, which adds further cardiovascular strain.
ARPKD Works Differently
While ADPKD develops cysts that can grow to several centimeters each, ARPKD produces many tiny cysts formed from dilated collecting ducts in the kidney. The PKHD1 gene makes a protein called fibrocystin, which also localizes to primary cilia and helps regulate cell growth. When fibrocystin is absent or dysfunctional, the same general theme applies: cells grow incorrectly and fluid accumulates. But ARPKD also commonly affects the liver, causing a buildup of scar tissue in the bile ducts that can lead to significant liver disease alongside the kidney problems. The severity varies widely. Some children present with massively enlarged kidneys at birth, while others aren’t diagnosed until later in childhood.